A monoclonal antibody to the microtubuleassociated protein X (tau) labeled some neurofibrillary tangles and plaque neurites, the two major locations of paired-helical
In Alzheimer disease/senile dementia of the Alzheimer type (AD/SDAT) the most characteristic neuropathological lesion is the accumulation of paired-helical filaments (PHF) . These abnormal cytoskeletal fibrils accumulate as neurofibrillary tangles in neuronal cell bodies and in the neurites of the neuritic (senile) plaques. Each PHF is made up of eight protofilaments, 3-5 nm in diameter (1) . The PHF protofilaments differ ultrastructurally from those of normal neurofibrils (2) . Biochemical studies of the PHF have been hampered because of difficulties in their isolation and solubilization. A purification procedure for PHF has enabled partial characterization of component polypeptides by NaDodSO4/ PAGE (3) . Subsequent studies with both polyclonal and monoclonal antibodies (mAb) to PHF have demonstrated that polypeptides from 45 to 62 kDa are PHF specific (4, 5) . Since these PHF polypeptides were also labeled by antibodies to microtubule proteins, but not by antibodies to tubulin (5) (6) (7) , it appeared possible that they might belong to the heterogeneous group of microtubule-associated proteins, called 7 (tau) (8) . Using an mAb to 7, the present study demonstrates that T in Alzheimer brain is atypically phosphorylated and is a component of PHF.
MATERIALS AND METHODS
Antibodies and Immunological Reagents. mAb tau-1 to T was generated in mice using NaDodSO4-denatured microtubule-associated proteins from bovine brain and affinity purified by protein A-Sepharose chromatography (9) . The tau-1 antibody recognizes r from calf, rat, and human brain, and the epitope recognized seems confined exclusively to T (9, 10). In the experiments described below tau-1 was employed at a concentration of 0.1 ,ug/ml. Antiserum to isolated PHF (4) was diluted at 1:1000. PHF-reactive antiserum to calf microtubules (anti-MT II serum), antiserum to microtubules (anti-MT IV serum), and antiserum to neurofilaments have been described (4, 7) . These three antisera were used for immunoblots at 1:3000, 1:1000, and 1:2000 dilutions, respectively. The two latter antisera do not react with PHF. Commercially available antibodies used were affinity purified antibodies to tubulin [CAABCO, Houston, TX; 1 ,ug/ml ( 
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at 43 ug/ml together with 250 mM phosphate, or (iv) 2.5 mM EDTA and 2.5 mM EGTA.
PHFs were isolated from the brain of a 72-year-old Alzheimer patient using the long procedure of Iqbal et al. (3) . Microtubules were prepared from the cerebrum of an 83-year-old Alzheimer patient and from two normal individuals, 40 and 81 years old, by in vitro assembly (13) .
Protein Determination, NaDodSO4/PAGE and Immunoblots. Protein concentrations were estimated by the method of Lowry et al. (14) as modified (3) and verified by amino acid analysis and Coomassie blue-stained gels. NaDodSO4/ PAGE (80 x 60 x 0.75 mm slab) was performed according to Laemmli (15) . Sample preparation was as described (3) . The isolated PHF were solubilized by ultrasonication for 30 min (3) (17) . For dephosphorylation experiments the blots were blocked in 20% (wt/vol) bovine serum albumin (crystalized, Sigma) in Tris buffer and incubated with alkaline phosphatase at 43 ,g/ml (12) .
RESULTS
Staining of tangles and plaque neurites by the mAb to r was observed in hippocampus tissue sections from two of the six AD/SDAT patients (Fig. la) . In the remaining four patients only rare tangles and plaques were immunolabeled (Fig. ld) . In contrast dephosphorylation (43 ,g of alkaline phosphatase per ml) of the adjacent sections prior to labeling with mAb to r changed the staining pattern dramatically: in all six AD/SDAT individuals studied apparently every tangle present, identified by Bodian silver stain of the neighboring section, was intensely stained by the antibody (Fig. 1 b and  e) . In some neurons darkly stained outlines of cytoplasmic vacuoles of granulovacuolar degeneration were observed (Fig. ig) , a lesion frequently present in the hippocampal pyramidal neurons in AD/SDAT. In some of the affected areas staining of innumerable short thread-like structures scattered throughout the neuropil was striking after dephosphorylation (Fig. le) . Similar labeling of the neuropil has also been described with antisera raised against PHF (4). These neuropil threads have been shown to contain accumulations ofPHF (18) . Although the neurites of the plaques were darkly stained by anti-T antibody, immunolabeling of their amyloid cores was not seen (Fig. ic) (Fig. lh) . Postmortem intervals up to 24 hr did not appear to affect the immunostaining results.
PHF are surrounded by a coat of amorphous material that disappears after short exposure of a tangle-enriched fraction to 2% (wt/vol) NaDodSO4 at room temperature (3). To study whether the antigen recognized by anti-r antibody might be a contaminant, a tangle-enriched fraction was prepared under nondenaturing conditions (3) and treated with 2% (wt/vol) NaDodSO4 for 5 min at room temperature. Twice the material was pelleted and heated with 2% (wt/vol) NaDodSO4 in a boiling water bath for 5 min. Significant numbers of tangles were lost by this treatment. Immunolabeling of samples (11) taken after each of these detergent treatments showed that the antibody bound to tangles isolated under nondenaturing conditions as well as tangles that had been washed extensively with NaDodSO4 (Fig. ii) . These findings indicated that T was intrinsic to PHF.
Only very faint immunolabeling of the PHF polypeptides by anti-T antibody was seen on immunoblots of the PHF preparation (Figs. 2 and 3) . However, when the blots were treated with alkaline phosphatase (43 pug/ml) prior to application of the antibody, 4 or 5 polypeptide bands with Mr ranging from about 55,000 to 62,000 were distinctly labeled (Figs. 2 and 3 ). In addition, immunolabeling of material at the top of spacer and resolving gels, a smear along most of the lane, and several polypeptides of Mr below 45,000 was also observed. A comparison of PHF polypeptides labeled with PHF-reactive anti-microtubule serum and with antiserum to isolated PHF revealed that the major polypeptides labeled by these antibodies had the same electrophoretic mobilities as the 55-to 62-kDa polypeptides labeled by mAb to r (Fig. 2) ; both of these antisera have been shown to label the same PHF polypeptides as the mAb to isolated PHF (5) . In contrast to the mAb to r, the PHF-reactive anti-microtubule serum and the monoclonal and polyclonal antibodies to PHF recognized both phosphorylated and dephosphorylated forms of PHF polypeptides (data not shown).
PHF isolated by the procedure used in this study are highly purified (3), and on immunoblots tubulin, high molecular weight microtubule-associated proteins, or neurofilament triplet polypeptides were not detected using the following antibodies: affinity-isolated antibodies to tubulin; antiserum to calf microtubules; antiserum to neurofilaments; mAb to neurofilament polypeptide P68; and mAb SMI 31 and 34 to phosphorylated epitopes shared by neurofilament polypeptides P200 and P150. One of these antibodies, SMI 34, labels Alzheimer neurofibrillary tangles in tissue sections because of a phosphorylated epitope shared between neurofilaments and PHF. On immunoblots, however, this antibody only labeled the neurofilament (Fig. 2, lane 4 , NF) not the PHF polypeptides (Fig. 2, lane 4, PHF) . These results suggest that the reactivity of SMI 34 with PHF in tissue sections is most likely due to an assembled topographic rather than a sequential epitope. However, the possibility that the epitope consists of a continuous sequence of amino acids and was lost during the isolation of PHF cannot be eliminated.
The PHF polypeptide bands labeled by mAb to r had the same electrophoretic mobilities as the T polypeptides in the microtubule protein preparations (Fig. 3) . However, like r in PHF, T in the Alzheimer microtubule fraction had to be dephosphorylated to be fully recognized by the T mAb. The immunostaining of the T polypeptides in the Alzheimer microtubule preparation, especially the two slowest moving molecular species, was enhanced by dephosphorylation (Fig.  3, lane B*) , whereas dephosphorylation did not significantly change the staining of X in microtubules from normal individuals studied (Fig. 3, lanes C) . 
DISCUSSION
This study (i) demonstrates the similarity of X and the major PHF polypeptides by their immunological crossreactivity and similar mobilities in NaDodSO4/PAGE and (ii) shows that Tin Alzheimer brain is abnormally phosphorylated. This phosphorylation appears to make a highly conserved r epitope inaccessible to a mAb to r. These data suggest that phosphorylation of might be a factor in the formation of the PHF. Such a defect in AD/SDAT might be caused by an inbalance of the protein kinase-phosphatase system, involving either (i) increase of a certain protein kinase activity or (ii) reduction in the level of phosphatase activity that normally would control phosphorylation. (5) . The far left lane shows the Coomassie blue-stained polypeptide pattern of isolated PHF (5-30% acrylamide gradient).
Protein phosphorylation is believed to be one of the major mechanisms for regulation of cellular function. Tr is a phosphoprotein (19) . It was discovered and is best known for promoting the in vitro assembly of microtubules (8) . The interaction of T with other brain proteins appears to be regulated by phosphorylation. The in vitro phosphorylation of r has been reported to inhibit both the polymerization of tubulin (20) and the interaction of microtubules with actin filaments (19) . Furthermore, preliminary data suggest a defect in microtubule assembly in AD/SDAT (21 . . w e n c h : i : ! : § -R X i : :
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a. tau Coomassie blue-stained patterns of X purified from calf brain (10) (lane E).
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